• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肽键的荧光配体对组胺 H 受体的优化。

Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H Receptor.

机构信息

Division of Biomolecular Science and Medicinal Chemistry, School of Pharmacy, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, U.K.

Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, the Midlands, Nottingham NG7 2UH, U.K.

出版信息

J Med Chem. 2022 Jun 23;65(12):8258-8288. doi: 10.1021/acs.jmedchem.2c00125. Epub 2022 Jun 3.

DOI:10.1021/acs.jmedchem.2c00125
PMID:35734860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9234962/
Abstract

The histamine H receptor (HR) has recently been implicated in mediating cell proliferation and cancer progression; therefore, high-affinity HR-selective fluorescent ligands are desirable tools for further investigation of this behavior in vitro and in vivo. We previously reported a HR fluorescent ligand, bearing a peptide-linker, based on antagonist VUF13816 and sought to further explore structure-activity relationships (SARs) around the linker, orthostere, and fluorescent moieties. Here, we report a series of high-affinity HR fluorescent ligands varying in peptide linker composition, orthosteric targeting moiety, and fluorophore. Incorporation of a boron-dipyrromethene (BODIPY) 630/650-based fluorophore conferred high binding affinity to our HR fluorescent ligands, remarkably overriding the linker SAR observed in corresponding unlabeled congeners. Compound , both potent and subtype-selective, enabled HR visualization using confocal microscopy at a concentration of 10 nM. Molecular docking of with the human HR predicts that the optimized peptide linker makes interactions with key residues in the receptor.

摘要

组胺 H 受体(HR)最近被牵涉到介导细胞增殖和癌症进展中;因此,高亲和力的 HR 选择性荧光配体是进一步研究这种体外和体内行为的理想工具。我们之前报道了一种基于拮抗剂 VUF13816 的带有肽连接子的 HR 荧光配体,并试图进一步探索连接子、正位体和荧光部分周围的构效关系(SAR)。在这里,我们报告了一系列具有不同肽连接子组成、正位靶向部分和荧光团的高亲和力 HR 荧光配体。在我们的 HR 荧光配体中引入硼二吡咯甲川(BODIPY)630/650 基荧光团赋予了高结合亲和力,显著克服了在相应未标记同系物中观察到的连接子 SAR。化合物 ,具有高活性和亚型选择性,能够在 10 nM 的浓度下使用共聚焦显微镜可视化 HR。与人类 HR 的分子对接预测,优化的肽连接子与受体中的关键残基相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/04164b5f4e15/jm2c00125_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/1d482c01929d/jm2c00125_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/3f659bb1eb89/jm2c00125_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/666c5c273328/jm2c00125_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/61362976f3a0/jm2c00125_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/85255d33f89f/jm2c00125_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/a465449edbb7/jm2c00125_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/3b9e3a2866db/jm2c00125_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/b04338efcf74/jm2c00125_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/ee1f595e04d8/jm2c00125_0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/c5df51ccf4b7/jm2c00125_0019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/1b7f8a380b51/jm2c00125_0020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/51f9f4afc8f2/jm2c00125_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/a9192d995cc8/jm2c00125_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/5a35b6d3e9c4/jm2c00125_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/3eed85df8779/jm2c00125_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/c71e68d75f40/jm2c00125_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/f61b3c15fab3/jm2c00125_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/712e8fae4018/jm2c00125_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/04164b5f4e15/jm2c00125_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/1d482c01929d/jm2c00125_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/3f659bb1eb89/jm2c00125_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/666c5c273328/jm2c00125_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/61362976f3a0/jm2c00125_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/85255d33f89f/jm2c00125_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/a465449edbb7/jm2c00125_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/3b9e3a2866db/jm2c00125_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/b04338efcf74/jm2c00125_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/ee1f595e04d8/jm2c00125_0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/c5df51ccf4b7/jm2c00125_0019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/1b7f8a380b51/jm2c00125_0020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/51f9f4afc8f2/jm2c00125_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/a9192d995cc8/jm2c00125_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/5a35b6d3e9c4/jm2c00125_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/3eed85df8779/jm2c00125_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/c71e68d75f40/jm2c00125_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/f61b3c15fab3/jm2c00125_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/712e8fae4018/jm2c00125_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af43/9234962/04164b5f4e15/jm2c00125_0011.jpg

相似文献

1
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H Receptor.基于肽键的荧光配体对组胺 H 受体的优化。
J Med Chem. 2022 Jun 23;65(12):8258-8288. doi: 10.1021/acs.jmedchem.2c00125. Epub 2022 Jun 3.
2
Docking and MD study of histamine H4R based on the crystal structure of H1R.基于 H1R 晶体结构的组胺 H4R 的对接和 MD 研究。
J Mol Graph Model. 2013 Feb;39:1-12. doi: 10.1016/j.jmgm.2012.10.003. Epub 2012 Oct 23.
3
2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.2,4-二氨基嘧啶作为组胺H1和H4受体的双重配体——H1/H4受体选择性
Bioorg Med Chem Lett. 2016 Jan 15;26(2):292-300. doi: 10.1016/j.bmcl.2015.12.035. Epub 2015 Dec 11.
4
Development of novel fluorescent histamine H-receptor antagonists to study ligand-binding kinetics in living cells.开发新型荧光组氨酸 H 受体拮抗剂,以研究活细胞中的配体结合动力学。
Sci Rep. 2018 Jan 25;8(1):1572. doi: 10.1038/s41598-018-19714-2.
5
Vasopeptidase-activated latent ligands of the histamine receptor-1.血管肽酶激活的组氨酸受体-1 的潜伏配体。
Int Immunopharmacol. 2013 Nov;17(3):677-83. doi: 10.1016/j.intimp.2013.08.014. Epub 2013 Sep 7.
6
8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist.8R-利苏瑞ide是一种强效的立体特异性组胺H1受体部分激动剂。
Mol Pharmacol. 2004 Mar;65(3):538-49. doi: 10.1124/mol.65.3.538.
7
Characterization of interactions between local anesthetics and histamine H receptor by cell membrane chromatography model.细胞膜色谱模型研究局麻药与组胺 H 受体相互作用。
J Pharm Biomed Anal. 2021 Mar 20;196:113911. doi: 10.1016/j.jpba.2021.113911. Epub 2021 Jan 19.
8
Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.嗜酸性粒细胞性食管炎(EoE)中食管组胺受体表达的改变:对疾病发病机制的影响
PLoS One. 2015 Feb 27;10(2):e0114831. doi: 10.1371/journal.pone.0114831. eCollection 2015.
9
Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor--H1/H4 receptor selectivity.阿司咪唑衍生化合物在组胺 H1 和 H4 受体上的药理学特性--H1/H4 受体选择性。
Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):235-50. doi: 10.1007/s00210-013-0926-4. Epub 2013 Nov 17.
10
The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study.组胺H1和H4受体在特应性皮炎中的作用:从基础研究到临床研究
Allergol Int. 2014 Dec;63(4):533-42. doi: 10.2332/allergolint.13-RA-0675.

引用本文的文献

1
A novel and selective fluorescent ligand for the study of adenosine A receptors.一种新型、选择性的荧光配体,用于研究腺苷 A 受体。
Pharmacol Res Perspect. 2024 Aug;12(4):e1223. doi: 10.1002/prp2.1223.
2
Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y Receptor.一种新型P2Y受体化学类型荧光配体的设计、合成与评价
ACS Med Chem Lett. 2024 Jun 12;15(7):1127-1135. doi: 10.1021/acsmedchemlett.4c00211. eCollection 2024 Jul 11.
3
BODIPY-Based Molecules for Biomedical Applications.基于 BODIPY 的分子在生物医学中的应用。

本文引用的文献

1
Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells.在活细胞中用荧光标签对G蛋白偶联受体进行配体导向的共价标记。
Commun Biol. 2020 Nov 27;3(1):722. doi: 10.1038/s42003-020-01451-w.
2
Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A Receptor.亚型选择性荧光配体作为人类腺苷 A 受体的药理学研究工具。
J Med Chem. 2020 Mar 12;63(5):2656-2672. doi: 10.1021/acs.jmedchem.9b01856. Epub 2020 Jan 9.
3
Visualizing endogenous opioid receptors in living neurons using ligand-directed chemistry.
Biomolecules. 2023 Nov 30;13(12):1723. doi: 10.3390/biom13121723.
4
Chemical biology fluorescent tools for investigation of the multidrug resistant P-glycoprotein (P-gp) expression in tumor cells.用于研究肿瘤细胞中多药耐药性P-糖蛋白(P-gp)表达的化学生物学荧光工具。
RSC Adv. 2023 Sep 8;13(39):27016-27035. doi: 10.1039/d3ra05093a.
利用配体导向化学技术在活神经元中可视化内源性阿片受体。
Elife. 2019 Oct 7;8:e49319. doi: 10.7554/eLife.49319.
4
Route to Prolonged Residence Time at the Histamine H Receptor: Growing from Desloratadine to Rupatadine.延长组胺 H 受体驻留时间的途径:从地氯雷他定到鲁帕他定。
J Med Chem. 2019 Jul 25;62(14):6630-6644. doi: 10.1021/acs.jmedchem.9b00447. Epub 2019 Jul 5.
5
NanoBRET: The Bright Future of Proximity-Based Assays.纳米生物发光共振能量转移技术:基于邻近分析的光明未来。
Front Bioeng Biotechnol. 2019 Mar 26;7:56. doi: 10.3389/fbioe.2019.00056. eCollection 2019.
6
A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A receptor.活细胞 NanoBRET 结合测定法可用于研究配体与腺苷 A 受体的结合动力学。
Purinergic Signal. 2019 Jun;15(2):139-153. doi: 10.1007/s11302-019-09650-9. Epub 2019 Mar 27.
7
Histamine receptors and cancer pharmacology: an update.组胺受体与癌症药理学:最新进展。
Br J Pharmacol. 2020 Feb;177(3):516-538. doi: 10.1111/bph.14535. Epub 2018 Dec 13.
8
Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H and H Receptors on Living Cells.用于活细胞组胺 H 和 H 受体的均相、实时 NanoBRET 结合分析。
Mol Pharmacol. 2018 Dec;94(6):1371-1381. doi: 10.1124/mol.118.113373. Epub 2018 Sep 24.
9
Fluorescent probes for G-protein-coupled receptor drug discovery.用于 G 蛋白偶联受体药物发现的荧光探针。
Expert Opin Drug Discov. 2018 Oct;13(10):933-947. doi: 10.1080/17460441.2018.1518975. Epub 2018 Sep 24.
10
Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET.使用纳米生物发光共振能量转移技术在体内可视化配体与G蛋白偶联受体的结合
iScience. 2018 Aug 31;6:280-288. doi: 10.1016/j.isci.2018.08.006. Epub 2018 Aug 11.